BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2023 Earnings Call Transcript

Operator: Welcome to the BioMarin Pharmaceuticals First Quarter Investor Update Call. Hosting the conference call today from BioMarin is Traci McCarty, Group Vice President, Investor Relations.

Related Keywords

New York ,United States ,Japan ,France ,Argentina ,Saudi Arabia ,Germany ,Italy ,America ,German ,American ,Jean Jacques Bienaime ,Geoffrey Meacham ,Henry Fuchs ,Geoff Meacham ,Jeff Ajer ,Jeffrey Ajer ,Hank Fuchs ,Piper Sandler ,Christopher Raymond ,Traci Mccarty ,Brian Mueller ,Salveen Richter ,Greg Guyer ,Chris Raymond ,Nasdaq ,Group Vice ,Biomarin Pharmaceutical Inc ,Worldwide Research ,Biomarin Pharmaceuticals First Quarter Investor Update Call ,Health Photo ,Exchange Commission ,Institute For Clinical ,Drug Administration ,Goldman Sachs ,Biomarin Pharmaceutical ,Call Transcript April ,Marin Pharmaceutical ,Group Vice President ,Chief Executive Officer ,Executive Vice President ,Chief Commercial Officer ,Chief Technical Officer ,Chief Financial ,Jacques Bienaime ,Outcomes Based Agreements ,Myriam Zilles ,Latin American ,Outcomes Based ,Named Patient ,Beyond Germany ,Economic Review ,United States Food ,Biologics License Application ,Duchenne Muscular Dystropy ,Largest Declines ,Kevino Leary ,Stock Portfolio ,